DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2220913/countdown-to-thomson-reuters-tri-q4-earnings-wall-street-forecasts-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2220913 Feb 05, 2024 - Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Thomson Reuters (TRI), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023. 0

https://www.zacks.com/stock/news/2220914/insights-into-wex-wex-q4-wall-street-projections-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2220914 Feb 05, 2024 - Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Wex (WEX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023. 0

https://www.zacks.com/stock/news/2220909/nvent-nvt-q4-earnings-on-the-horizon-analysts-insights-on-key-performance-measures?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2220909 Feb 05, 2024 - Besides Wall Street's top -and-bottom-line estimates for nVent (NVT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023. 0

https://www.zacks.com/stock/news/2220910/curious-about-dexcom-dxcm-q4-performance-explore-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2220910 Feb 05, 2024 - Evaluate the expected performance of DexCom (DXCM) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. 0

https://www.zacks.com/stock/news/2220911/unlocking-q4-potential-of-kellanova-k-exploring-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2220911 Feb 05, 2024 - Beyond analysts' top -and-bottom-line estimates for Kellanova (K), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023. 0

https://www.zacks.com/stock/news/2220920/what-analyst-projections-for-key-metrics-reveal-about-philip-morris-pm-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2220920 Feb 05, 2024 - Besides Wall Street's top -and-bottom-line estimates for Philip Morris (PM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023. 0

https://www.zacks.com/stock/news/2220917/insights-into-maximus-mms-q1-wall-street-projections-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2220917 Feb 05, 2024 - Evaluate the expected performance of Maximus (MMS) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. 0

https://www.zacks.com/stock/news/2220918/stay-ahead-of-the-game-with-lincoln-national-lnc-q4-earnings-wall-street-s-insights-on-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2220918 Feb 05, 2024 - Besides Wall Street's top -and-bottom-line estimates for Lincoln National (LNC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023. 0

https://www.zacks.com/stock/news/2220915/gear-up-for-omega-healthcare-investors-ohi-q4-earnings-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2220915 Feb 05, 2024 - Besides Wall Street's top -and-bottom-line estimates for Omega Healthcare Investors (OHI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023. 0

https://www.zacks.com/stock/news/2220916/unveiling-boyd-byd-q4-outlook-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2220916 Feb 05, 2024 - Besides Wall Street's top -and-bottom-line estimates for Boyd (BYD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023. 0